Previous Article | Next Article 
Journal of Clinical Microbiology, September 2006, p. 3292-3298, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.00539-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
Leen-Jan van Doorn,1*
Anco Molijn,1
Bernhard Kleter,1
Wim Quint,1 and
Brigitte Colau2
DDL Diagnostic Laboratory, Fonteijnenburghlaan 5, Voorburg, The Netherlands,1
GSK Biologicals, Rue de l'Institut 89, Rixensart, Belgium2
Received 13 March 2006/
Returned for modification 8 June 2006/
Accepted 19 June 2006
The use of a single broad-spectrum human papillomavirus (HPV) DNA-based PCR test may fail to detect lower concentrations of HPV DNA due to competition between different genotypes in mixed infections. To improve HPV detection by PCR, broad-spectrum and type-specific (TS) PCRs were combined, with a focus on HPV-16 and HPV-18. Cervical and cervicovaginal cell samples were obtained from 1,113 healthy women (age range, 15 to 25 years) participating in an HPV-16/HPV-18 candidate vaccine efficacy trial. These samples were tested by a broad-spectrum SPF10 PCR-DNA enzyme immunoassay, followed by a primer SPF10-based line probe assay (SPF10 LiPA), and HPV-16- and HPV-18-TS PCRs. The results for the majority of the HPV-16/18 SPF10 LiPA-positive samples were confirmed by TS-PCR (kappa values, 0.775 for HPV-16 and 0.785 for HPV-18). However, TS PCR revealed additional positive samples among those that contained other HPV genotypes due to competition. Conversely, SPF10 LiPA identified HPV-16 or -18 in samples that remained negative by TS PCR as a result of sampling variation. Analysis of follow-up samples from more than 1,000 women confirmed that the combination of SPF10-LiPA with additional HPV-16- and HPV-18-TS PCR diminishes the rate of false-negative diagnosis. The combination of broad-spectrum and TS PCRs resulted in a novel testing algorithm. This combination of assays is more accurate than either method alone, and the novel algorithm offers a highly accurate and effective method for the analysis of HPV infections.
* Corresponding author. Mailing address: DDL Diagnostic Laboratory, Fonteijnenburghlaan 5, 2275 CX, Voorburg, The Netherlands. Phone: 31-70-3401670. Fax: 31-70-3401671. E-mail:
L.J.van.Doorn{at}ddl.nl.
Journal of Clinical Microbiology, September 2006, p. 3292-3298, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.00539-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Iftner, T., Germ, L., Swoyer, R., Kjaer, S. K., Breugelmans, J. G., Munk, C., Stubenrauch, F., Antonello, J., Bryan, J. T., Taddeo, F. J.
(2009). Study Comparing Human Papillomavirus (HPV) Real-Time Multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV Genotyping PCR Assays. J. Clin. Microbiol.
47: 2106-2113
[Abstract]
[Full Text]
-
Dal Bello, B., Spinillo, A., Alberizzi, P., Cesari, S., Gardella, B., Silini, E. M.
(2009). Validation of the SPF10 LiPA Human Papillomavirus Typing Assay Using Formalin-Fixed Paraffin-Embedded Cervical Biopsy Samples. J. Clin. Microbiol.
47: 2175-2180
[Abstract]
[Full Text]
-
Castle, P. E., Porras, C., Quint, W. G., Rodriguez, A. C., Schiffman, M., Gravitt, P. E., Gonzalez, P., Katki, H. A., Silva, S., Freer, E., Van Doorn, L.-J., Jimenez, S., Herrero, R., Hildesheim, A., for the CVT Group,
(2008). Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods. J. Clin. Microbiol.
46: 3437-3445
[Abstract]
[Full Text]
-
Sabol, I., Salakova, M., Smahelova, J., Pawlita, M., Schmitt, M., Gasperov, N. M., Grce, M., Tachezy, R.
(2008). Evaluation of Different Techniques for Identification of Human Papillomavirus Types of Low Prevalence. J. Clin. Microbiol.
46: 1606-1613
[Abstract]
[Full Text]
-
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., Jimenez, S. E., Lowy, D. R., for the Costa Rican HPV Vaccine Trial Group,
(2007). Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection: A Randomized Trial. JAMA
298: 743-753
[Abstract]
[Full Text]
-
Stevens, M. P., Garland, S. M., Rudland, E., Tan, J., Quinn, M. A., Tabrizi, S. N.
(2007). Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results. J. Clin. Microbiol.
45: 2130-2137
[Abstract]
[Full Text]
-
de Koning, M. N. C., Struijk, L., Bavinck, J. N. B., Kleter, B., ter Schegget, J., Quint, W. G. V., Feltkamp, M. C. W.
(2007). Betapapillomaviruses frequently persist in the skin of healthy individuals. J. Gen. Virol.
88: 1489-1495
[Abstract]
[Full Text]
-
Safaeian, M., Herrero, R., Hildesheim, A., Quint, W., Freer, E., Van Doorn, L.-J., Porras, C., Silva, S., Gonzalez, P., Bratti, M. C., Rodriguez, A. C., Castle, P., for the Costa Rican Vaccine Trial Group,
(2007). Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica. J. Clin. Microbiol.
45: 1447-1454
[Abstract]
[Full Text]
-
Fontaine, V., Mascaux, C., Weyn, C., Bernis, A., Celio, N., Lefevre, P., Kaufman, L., Garbar, C.
(2007). Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens. J. Clin. Microbiol.
45: 928-934
[Abstract]
[Full Text]